Skip to main content
2024 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Thilak Mudalige, PhD (he/him/his)

RESEARCH CHEMIST
US Food and Drug Administration
Jefferson, Arkansas

Thilak Mudalige is a research chemist at NCTR-ORA nanotechnology core facility of US FDA. He is developing novel methods for the characterization of nanomedicine, which include analysis of lipid based fomulation for distribution of active pharmaceutical ingredients, drug release profiling, quantitation of excipients and excipient related impurities, developing drug release profiling methods for protein and lipid-based formulations. His prior experiences include the synthesis, characterization, and application of nanomaterials and bio-nanomaterials composites. Dr. Mudalige is a recipient of multiple awards including ORA scientist of the year award in 2016 and his collaborative work received FDA excellence in analytical science group award in 2019.

Disclosure information not submitted.

Presentation(s):